Inspire Medical (INSP) officer awarded shares, RSUs and tax withholding

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Inspire Medical Systems officer John Rondoni reported equity compensation and related tax withholding in company stock. He acquired 2,400 shares of common stock at no cost upon satisfaction of performance conditions tied to earlier performance stock units, and 15,958 additional shares through a new stock award.

To cover taxes from vesting of a performance stock unit award, 735 shares were withheld at a price of $59.53 per share. After these transactions, he directly owned 14,548 shares following the tax withholding and 30,506 shares following the new restricted stock unit award, which will vest in three equal annual installments starting February 20, 2027.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Rondoni John

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,400	$0.00	--
Tax Withholding	Common Stock	735	$59.53	$44K
Grant/Award	Common Stock	15,958	$0.00	--

Holdings After Transaction: Common Stock — 15,283 shares (Direct)

Footnotes (1)

Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/24/2026 - 06:57 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rondoni John

(Last)

(First)

(Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY

55416

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/20/2026		A		2,400⁽¹⁾	A	$0.00	15,283	D
Common Stock	02/20/2026		F		735⁽²⁾	D	$59.53	14,548	D
Common Stock	02/20/2026		A		15,958⁽³⁾	A	$0.00	30,506	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units.

2. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.

3. Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates.

Remarks:

Title: Chief Product and Innovation Officer.

	/s/ Bryan Phillips, Attorney-in-Fact for John Rondoni	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Inspire Medical Systems (INSP) report for John Rondoni?

John Rondoni reported equity compensation transactions in Inspire Medical Systems stock. He received common shares from performance-based awards and a new restricted stock unit grant, and had shares withheld to cover taxes tied to vesting, all recorded as direct ownership activity on February 20, 2026.

How many Inspire Medical Systems (INSP) shares did John Rondoni acquire in the latest filing?

He acquired 2,400 common shares at no cost after performance conditions were met, and 15,958 additional shares through a new stock award. These awards are classified as grant or award acquisitions rather than open-market purchases, reflecting equity-based executive compensation at Inspire Medical Systems.

Why were some Inspire Medical Systems (INSP) shares disposed of in John Rondoni’s Form 4?

The filing shows a tax-withholding disposition of 735 shares at $59.53 per share. These shares were withheld by Inspire Medical Systems to satisfy tax obligations triggered by vesting of a performance stock unit award, rather than representing an open-market sale by the officer.

What is the vesting schedule for John Rondoni’s new Inspire Medical Systems (INSP) RSU award?

The new award represents restricted stock units that vest in three equal annual installments beginning February 20, 2027. Each restricted stock unit entitles him to receive one share of Inspire Medical Systems common stock, contingent on his continuous employment through the applicable vesting dates.

How many Inspire Medical Systems (INSP) shares does John Rondoni own after these transactions?

After the tax-withholding disposition, he directly held 14,548 Inspire Medical Systems common shares. Following the additional restricted stock unit award reported as acquired, his total reported direct holdings increased to 30,506 shares, reflecting both existing ownership and the newly granted equity compensation.

What do the Form 4 footnotes reveal about Inspire Medical Systems (INSP) awards to John Rondoni?

The footnotes explain that 2,400 shares came from performance stock units meeting conditions, 735 shares were withheld for taxes upon vesting, and 15,958 units are restricted stock units vesting over three years, each convertible into one share of Inspire Medical Systems common stock upon vesting.